Literature DB >> 10785440

An altered histaminergic innervation of the substantia nigra in Parkinson's disease.

O V Anichtchik1, J O Rinne, H Kalimo, P Panula.   

Abstract

The central histaminergic system is one of the subcortical aminergic projection systems involved in several regulatory functions. The central dopaminergic and histaminergic systems interact extensively, but little is known about the histaminergic system in diseases affecting the dopaminergic neurons. The distribution of histaminergic fibers in the substantia nigra (SN) in postmortem brain samples from patients suffering from Parkinson's disease (PD) and normal controls was examined with a specific immunohistochemical method. Direct connections between dopaminergic neurones and histaminergic fibers were observed. Histamine in human SN was stored in fibers and varicosities. Sites of histamine formation were examined by l-histidine decarboxylase in situ hybridization. In both normal and PD brains HDC mRNA was found only in posterior hypothalamus and not in SN. The presence of histaminergic innervation of the human substantia nigra pars compacta (SNc) and reticulata (SNr), paranigral nucleus, radix of oculomotor nerve, and parabrachial pigmented nucleus was demonstrated. The density of histaminergic fibers in the middle portion of SNc and SNr was increased in brains with PD. In PD the morphology of histaminergic fibers was also altered; they were thinner than in controls and had enlarged varicosities. An increase of histaminergic innervation may reflect a compensatory event due to deficiency of, e.g., dopamine or a putative fiber growth inhibitory factor. Whether the changes seen in histaminergic fibers in PD are primary or secondary remains to be investigated. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10785440     DOI: 10.1006/exnr.2000.7362

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  36 in total

1.  Histamine Excites Striatal Dopamine D1 and D2 Receptor-Expressing Neurons via Postsynaptic H1 and H2 Receptors.

Authors:  Qian-Xing Zhuang; Han-Ting Xu; Xu-Juan Lu; Bin Li; Wing-Ho Yung; Jian-Jun Wang; Jing-Ning Zhu
Journal:  Mol Neurobiol       Date:  2018-03-01       Impact factor: 5.590

2.  Effect of pre- and postnatal manganese exposure on brain histamine content in a rodent model of Parkinson's disease.

Authors:  Ryszard Brus; Jerzy Jochem; Przemysław Nowak; Marta Adwent; Dariusz Boroń; Halina Brus; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2011-08-06       Impact factor: 3.911

3.  A Novel Developmental Role for Dopaminergic Signaling to Specify Hypothalamic Neurotransmitter Identity.

Authors:  Yu-Chia Chen; Svetlana Semenova; Stanislav Rozov; Maria Sundvik; Joshua L Bonkowsky; Pertti Panula
Journal:  J Biol Chem       Date:  2016-08-18       Impact factor: 5.157

4.  Greatly increased numbers of histamine cells in human narcolepsy with cataplexy.

Authors:  Joshi John; Thomas C Thannickal; Ronald McGregor; Lalini Ramanathan; Hiroshi Ohtsu; Seiji Nishino; Noriaki Sakai; Akhiro Yamanaka; Carly Stone; Marcia Cornford; Jerome M Siegel
Journal:  Ann Neurol       Date:  2013-09-10       Impact factor: 10.422

5.  Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease.

Authors:  José A G Agúndez; Antonio Luengo; Oscar Herráez; Carmen Martínez; Hortensia Alonso-Navarro; Félix Javier Jiménez-Jiménez; Elena García-Martín
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

6.  Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor.

Authors:  Brett H Keeling; Carles Vilariño-Güell; Alexandra I Soto-Ortolaza; Owen A Ross; Ryan J Uitti; Alex Rajput; Zbigniew K Wszolek; Matthew J Farrer
Journal:  Parkinsonism Relat Disord       Date:  2009-09-20       Impact factor: 4.891

7.  Histamine Excites Rat GABAergic Ventral Pallidum Neurons via Co-activation of H1 and H2 Receptors.

Authors:  Miao-Jin Ji; Xiao-Yang Zhang; Xiao-Chun Peng; Yang-Xun Zhang; Zi Chen; Lei Yu; Jian-Jun Wang; Jing-Ning Zhu
Journal:  Neurosci Bull       Date:  2018-08-25       Impact factor: 5.203

8.  Histamine is required for H₃ receptor-mediated alcohol reward inhibition, but not for alcohol consumption or stimulation.

Authors:  J Vanhanen; S Nuutinen; M Lintunen; T Mäki; J Rämö; K Karlstedt; P Panula
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

9.  Histaminergic activity in a rodent model of Parkinson's disease.

Authors:  Przemysław Nowak; Lukasz Noras; Jerzy Jochem; Ryszard Szkilnik; Halina Brus; Eva Körossy; Jacek Drab; Richard M Kostrzewa; Ryszard Brus
Journal:  Neurotox Res       Date:  2009-02-28       Impact factor: 3.911

10.  Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata.

Authors:  Sarah Threlfell; Stephanie J Cragg; Imre Kalló; Gergely F Turi; Clive W Coen; Susan A Greenfield
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.